SCHEMBL5866883

SCHEMBL5866883

O=[N+]([O-])c1cc(Br)cc2cc(/C(=N\O)Nc3cccc(Cl)c3)oc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 2/20 0.41
MAPT P10636 4/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
PAX8 Q06710 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALOX5 P09917 1/20 0.39
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
IDO1 P14902 2/20 0.39
HSPD1 P10809 1/20 0.36
HSPE1 P61604 1/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
MMP13 P45452 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
CBR1 P16152 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5866885 1.00 GPR35 (0.41) GPR35MAPTKDM4EGAAPAX8
SCHEMBL5866888 0.81 LMNA (0.52) GPR35MEN1KMT2AIDO1ALDH1A1
SCHEMBL5866846 0.76 MEN1 (0.52) MAPTKDM4ENPSR1L3MBTL1ALOX5
SCHEMBL5866847 0.76 MEN1 (0.52) MAPTKDM4ENPSR1L3MBTL1ALOX5
SCHEMBL7586299 0.75 GPR35 (0.42) GPR35MAPTKDM4EGAAMEN1
SCHEMBL5867088 0.73 CBR1 (0.44) MAPTL3MBTL1MEN1KMT2AIDO1
SCHEMBL5867078 0.73 CBR1 (0.44) MAPTL3MBTL1MEN1KMT2AIDO1
SCHEMBL5866920 0.71 MAPT (0.45) MAPTL3MBTL1MEN1KMT2AIDO1
SCHEMBL5866919 0.71 MAPT (0.45) MAPTL3MBTL1MEN1KMT2AIDO1
SCHEMBL5866832 0.71 CBR1 (0.45) GPR35MAPTKDM4EGAANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7148259-B1 Antibacterial agents AMGEN INC. (US) 2006-12-12 US disclosed
US-20060270651-A1 ANTIBACTERIAL AGENTS AMGEN INC. (US) 2006-11-30 US disclosed
US-7053234-B2 Antibacterial agents AMGEN INC. (US) 2006-05-30 US disclosed
US-20040235911-A1 hydroxyamidines; antibiotic resistance TULARIK INC. 2004-11-25 US disclosed
US-6780858-B2 Antibacterial agents TULARIK INC. 2004-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235911-A1 hydroxyamidines; antibiotic resistance HNMT, HDHD5, ABCC1 GPR35 3317/4885MAPT 3987/4885KDM4E 4648/4885
US-20060270651-A1 ANTIBACTERIAL AGENTS MRPL21, HDHD5, CLPP GPR35 4559/4885MAPT 4113/4885KDM4E 4511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.